Ask AI

Downloadable Living Slides

Share

Program Content

Activities

  • IL-13 Inhibitors in Moderate to Severe AD
    Team Trivia! Test Your Skills and Learn From Experts on IL-13 Inhibitors in Moderate to Severe Atopic Dermatitis
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: March 03, 2025

    Expires: March 02, 2026

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC in partnership with Practicing Clinicians Exchange, LLC and the National Eczema Association.

Supporters

This activity is supported by an educational grant from Lilly.

Lilly

Partners

National Eczema Association

ProCE Banner

Practicing Clinicians Exchange, LLC

ProCE Banner